Autolus Therapeutics (AUTL) Operating Income Growth (1y) (2020 - 2025)
Autolus Therapeutics (AUTL) Operating Income Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 1,386.07% |
| 10 | Autolus Therapeutics | 395.22 Mn | 94.51 Mn | -1.04 Mn | 4.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.48% |
| Sep 30, 2025 | -5.52% |
| Jun 30, 2025 | -3.88% |
| Mar 31, 2025 | -68.33% |
| Dec 31, 2024 | -42.41% |
| Sep 30, 2024 | -58.20% |
| Jun 30, 2024 | -32.79% |
| Mar 31, 2024 | 1.00% |
| Dec 31, 2023 | -357.26% |
| Sep 30, 2023 | -14.88% |
| Jun 30, 2023 | -13.60% |
| Mar 31, 2023 | -8.19% |
| Dec 31, 2022 | 49.57% |
| Sep 30, 2022 | 7.45% |
| Jun 30, 2022 | -3.55% |
| Mar 31, 2022 | 9.24% |
| Dec 31, 2021 | 51.19% |
| Sep 30, 2021 | 5.51% |
| Jun 30, 2021 | 4.60% |
| Mar 31, 2021 | -3.39% |